J0349 HCPCS code: Injection, rezafungin, 1 mg
J0349 is the HCPCS Level II code for injection, rezafungin, 1 mg. In 2024 Medicare paid an average of $7.59 per service for J0349 across 49,010 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 400 per day on outpatient hospital claims. In 2024, about 65 clinicians billed Medicare for J0349 for 55 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-10-01 |
| Last action effective | 2023-10-01 |
Who bills J0349 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 65 |
| Medicare beneficiaries | 55 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0349, 2024–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2024 | 49,010 | 55 | $9.53 | $7.59 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 400 | Prescribing Information |
| practitioner claims | 400 | Prescribing Information |
What changed for J0349
- 2023-10-01: J0349 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0349?
J0349 is the HCPCS Level II code for injection, rezafungin, 1 mg. Short descriptor: "Inj, rezafungin, 1 mg".
How much does Medicare pay for J0349?
In 2024, the average Medicare payment was $7.59 per service (average allowed $9.53).
Does Medicare cover J0349?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0349 can be billed per day?
400 on outpatient hospital claims; 400 on practitioner claims (NCCI medically unlikely edits).
Related J03 codes
- J0300 — Injection, amobarbital, up to 125 mg
- J0330 — Injection, succinylcholine chloride, up to 20 mg
- J0348 — Injection, anidulafungin, 1 mg
- J0350 — Injection, anistreplase, per 30 units
- J0360 — Injection, hydralazine hcl, up to 20 mg
- J0364 — Injection, apomorphine hydrochloride, 1 mg
- J0365 — Injection, aprotonin, 10,000 kiu
- J0380 — Injection, metaraminol bitartrate, per 10 mg
- J0390 — Injection, chloroquine hydrochloride, up to 250 mg
- J0391 — Injection, artesunate, 1 mg
- J0395 — Injection, arbutamine hcl, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0349
- Watch J0349 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0349
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.